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ABSTRACT: The aim of this study is to investigate the
potential of microﬂuidic techniques to generate microporous
structures, with potential utility as scaﬀolds, with a highly
uniform architecture, possessing an antibacterial activity.
Scaﬀolds were prepared by introducing N2 gas to gelatin
(GE)−water or gelatin/hyaluronic acid (GE/HA)−water
mixtures to form microbubbles at the interface. The eﬀect of
solution temperature on microbubble stability and their
structural integrity were studied. A solution temperature of
40 °C produced the best results due to the higher solution
viscosity. The eﬀect of diﬀerent cross-linking concentrations
on scaﬀold swelling ratio was investigated. A concentration of
5% glutaraldehyde was found to be optimal and was chosen to
cross-link structure and conduct subsequent degradation and antibacterial experiments. HA was incorporated into the scaﬀolds
owing to its ability to make stable and highly absorbent scaﬀolds. This led to a decrease in the degradation rate and the
introduction of an antibacterial eﬀect. This eﬀect could be further enhanced with the inclusion of lactoferrin. This work is the
ﬁrst reported attempt for making antibacterial GE/HA scaﬀolds by using microﬂuidics.
■ INTRODUCTION
Recently, remarkable research has been conducted to develop
bioactive scaﬀolds, which are analogous to the extracellular
matrix (ECM), that have a signiﬁcant impact in the ﬁeld of
tissue engineering, as their ideal ability to act as a conduit to
guide cell growth and subsequent tissue formation.1,2 The key
challenge is to produce scaﬀolds which facilitate tissue−cell
interactions while preventing bacterial colonization. Antibacte-
rial scaﬀolds have been applied in a broad range of tissue
engineering applications such as bone, cartilage, ligament, skin,
vascular tissues, neural tissues, and bone tissues. Their porosity
is the key factor in enhancing the transportation of nutrients
and oxygen.3 This has captured the attention of many
researchers keen to develop more eﬀective approaches for
obtaining porous scaﬀolds with improved characteristics.
Existing manufacturing techniques for porous scaﬀolds include
gas forming, electrospinning, phase separation, freeze drying,
and particulate leaching.4 All these techniques introduce
porosity since a porous surface not only allows the migration
and proliferation of cells but also vascularization.5 Scaﬀolds
produced via these conventional technologies have a wide
distribution of pore sizes or irregularities in their structures
consequently resulting in diﬃculties during the conduct of
systematic research aimed at investigating the eﬀect of
structure on the diﬀerences in signaling, gene expression, and
organization. Also, using these conventional methods to
produce scaﬀolds results in a lack of control over the structure
and interconnectivity of scaﬀolds, furthermore aﬀecting the
mechanical properties.6 Ordered and uniformed spatial
structures are beneﬁcial in the study of cell-to-cell and cell-
to-matrix interactions. A uniform spatial structure also
contributes to the homogeneous distribution of chemical
stimuli.7 In this study, the microﬂuidic technique is employed
to fabricate scaﬀolds with a desirable homogenous porosity,8
interconnectivity, and potential mechanical properties.6 This
process can be readily scaled up by incorporating multiple T-
junction devices into the production method.8 Wang et al.9
showed that by collecting bubbles over a period of time, the
fabrication of a sponge-type, multilayer scaﬀold was successful,
which promoted more cell migration and distribution in the
scaﬀold through chondrocyte proliferation. Ekemen et al.10
used microbubbling to fabricate scaﬀolds for tissue engineering
applications as their open pores are ideal for integration and
cell proliferation.
Three key factors need to be considered in the design of
ideal scaﬀolds intended to mimic the natural extracellular
matrix (ECM) of a targeted tissue. These are the scaﬀolds’
mechanical properties, structure, and biological signaling.11
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Natural ECM is comprised of a cross-linked porous structure
of collagens embedded with glycosaminoglycans and pro-
teins.2,12 Currently, a large number of extracellular matrix-
inspired protein and polysaccharide-based materials exist.12
Among them, hyaluronic acid (HA) as a natural skin
component is the most frequently used compound for soft
tissue ﬁllers. HA is a biocompatible, biodegradable natural
material composed of approximately 10 000 repeat units of the
disaccharide units of D-glucuronic acid and N-acetyl-D-
glucosamine.1,12 HA has many important roles in the body.
These include the good maintenance of extracellular space,
reinforcement of extracellular transportation of nutrients and
ions, manipulation of hydration of tissues, and binding of
interleukins and growth factors.12−14 It has also been shown
that HA interacting with proteins can facilitate natural ECM
assembly under physiological conditions.1,15 HA−protein
hybrids can stabilize ECM and subsequently regulate cell
adhesion and growth.16 As a result, HA has been widely used
as ideal scaﬀold materials for skin, cartilage, bone ligament,
brain and nerve tissue engineering applications.17−19 Despite
this, HA is not thermodynamically conducive to cell attach-
ment or tissue formation. These properties are a result of its
polyanionic and highly hydrophilicity nature.16,20 There are a
few methodologies to address this challenge. One of the major
approaches is to develop HA-based scaﬀolds in the presence of
nanoﬁbers, hydrogels, and sponges by integrating HA with
biomaterials such as collagen, gelatin, chitosan, and silk
ﬁbroin.1 HA has been chosen for this study as it has an
antimicrobial response.17,18,21
Collagen is the major protein component of ECM. As GE is
produced from collagen denaturation, it contains some of the
collagen precursor chemotactic signals (RGD amino acid
sequence, which can facilitate cell attachment). Thus, gelatin is
considered a cost-eﬀective replacement to collagen for the
various potential applications in tissue engineering.3 Gelatin is
broadly used as a material in the fabrication of scaﬀolds for
cartilage, bone, and nerve tissues.17 Gelatin also has a good gas
foaming ability and in this study was the major structural
component which was used to blend with HA to fabricate GE/
HA hybrid structures with potential use as scaﬀolds. The use of
natural materials as well as high porosity are two factors which
are implicated in bacterial growth as well as cell growth.
Lactoferrin (LF) is a glycoprotein and belongs to the
transferrin family, delivered from human or bovine milk.
Lactoferrin works as an opsonin to promote bacterial
clearance.21 LF binds the iron, resulting in sequestered iron,
which is one of the most necessary nutritional requirements for
most bacterial pathogens and thus inhibits the growth of a
broad spectrum of bacterial strains.21 It has been shown from
previous studies that lactoferrin has (i) the ability to promote
the proliferation and diﬀerentiation of osteoblasts, suggesting
its potential utility as an osteogenic growth factor in bone
tissue engineering,22 (ii) multiple functions including immu-
nomodulatory, anticancer, antibacterial, anti-inﬂammatory, and
antiviral activities.21,23 LF has been chosen for this study for its
antibacterial activity and its nontoxic eﬀects.24−26
In this study, antibacterial structures were generated to
prevent and limit infections without the use of antibiotics as its
long-term use can provoke toxic and adverse eﬀects. The need
for prevention of implant-associated bacterial infections has led
this research to combine microﬂuidics with the fabrication of
antibacterial scaﬀolds made from natural biomaterials. GE and
HA were chosen as the scaﬀold materials to mimic the vital
components of the ECM. The microﬂuidic technique was used
to generate monodispersed microbubbles which were the
precursors to the scaﬀolds. These scaﬀolds were cross-linked
with glutaraldehyde (GA). The operating temperature, cross-
linking concentrations, swelling ratio, and degradation were
also studied in this work. Moreover, the potential to
incorporate natural antibiotic agents into the scaﬀolds was
investigated in vitro by testing against Staphylococcus aureus. S.
aureus was chosen as a model bacteria for this study as it is a
major cause of nosocomial-acquired infections and can not
only provoke healthcare-associated infections such as ven-
tilator-associated pneumonia, surgical site infection, and
catheter-associated bloodstream infection but is also associated
with community-onset infections such as skin and soft tissues
infections.27,28
The aim of this study was to produce highly organized
porous structures and assess their antibacterial activity, as no
other study was found to have studied the antibacterial activity
of microbubble scaﬀolds. Gelatin and hyaluronic acid have
been used in several studies as scaﬀolding materials to mimic
components of the ECM, but this study is the ﬁrst that
combines GE/HA with LF to create antibacterial scaﬀolds
using microbubbles.
■ RESULTS AND DISCUSSION
Stability Test. GE microbubbles were generated using 5
w/w % GE solution heated to temperatures of 40, 50, or 60 °C
and delivered with a constant liquid ﬂow rate of 80 μL/min to
the T-junction microﬂuidic device. Gas pressure was adjusted
between 200 and 300 kPa to achieve approximately the same
initial bubble size. The average initial bubble size made from
these three solutions was 315 μm with a standard deviation of
7%. After processing, the scaﬀold pore size is proportional to
the diameter of the initially generated microbubbles. The
produced pore size is desirable as the pore size should be large
Table 1. Material Properties of 5 w/w % GE at 40, 50, and 60 °Ca
solution temperature (°C) viscosity (mPa s) density (g/mL) surface tension (mN/m)
5 w/w % GE/HW 40 25.27 ± 0.74 1.01 ± 0.02 54.6 ± 1.23
5 w/w % GE 40 19.85 ± 0.71 1.02 ± 0 03 43.52 ± 2.16
5 w/w % GE 50 5.66 ± 0.66* 1.06 ± 0.08 44.76 ± 0.03
5 w/w % GE 60 4.61 ± 0.43* 1.02 ± 0.007 41.74 ± 0.07
aEach measurement was repeated ﬁve times and values are expressed in mean ± standard error of the mean. One-way analysis of variance
(ANOVA) was carried out followed by post hoc Tukey multiple comparison test. GE solutions (5 wt %) at three diﬀerent temperature were
compared and values are represented statistically when *p < 0.05 in comparison with 5 wt % GE in 40° solution. Statistical analysis was performed
using the GraphPad Prism 6.0 software (GraphPad Software, Inc., San Diego, CA). There is no signiﬁcant diﬀerence in density and surface tension
between 5 wt % GE solutions at three diﬀerent temperatures. The viscosity of 5 wt % GE solution at 40° is signiﬁcantly higher (p < 0.05) compared
to the other two solutions at 50 and 60 °C.
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enough to allow communication between cells, access to
nutrition, and ECM formation. Murphy et al.29 show that the
cell proliferation was the highest in scaﬀolds with a pore size of
300 μm in comparison to smaller pore sizes, as cells can more
easily attach to large surfaces.30
To study the eﬀect of GE solution temperature on the
stability of the resulting microbubbles and the structure of
scaﬀolds produced by microbubbles after drying, material
properties of 5 w/w % GE solutions at 40, 50, or 60 °C were
measured (Table 1). Table 1 shows that amongst the three
diﬀerent temperatures, viscosity is the main parameter which
has substantially changed. Solution viscosity decreased, as the
water bath temperature was increased from 40 to 60 °C. The
highest solution viscosity is 19.85 ± 0.71 mPa s at 40 °C.
There is no signiﬁcant diﬀerence in density and surface tension
between 5 wt % GE solutions at three diﬀerent temperatures
with standard deviations of 0.01 and 1.5, respectively.
As demonstrated in Figure 1, the least stable microbubbles
were produced by solutions at 60 °C (Figure 1i), where
microbubbles started to dry out within 2 min without cross-
linking. On the other hand, microbubbles generated at 40 °C
(stable for up to 4 min without cross-linking) were observed to
be the most stable (Figure 1e). The stability diﬀerence is most
likely caused by the sharp viscosity contrast between 5 w/w %
GE at 40 and 60 °C (Table 1). The diﬀerence in viscosity also
contributes to the formation of scaﬀolds. Honeycomb-shaped
scaﬀolds were created with solutions heated to 40 °C (Figure
1h). Conversely, scaﬀolds with irregularities were formed with
solution heated up to 60 °C. This is a result of the lower shell
viscosity of the microbubbles, which is insuﬃcient to resist the
distortion forces caused by solvent evaporation.31 This is in
agreement with previous reports that increasing the viscosity of
the continuous phase can prolong the life span of the droplets
surrounded by polymer.6 This in turn reduces the number of
defects which are evident in Figure 1m−p for solution at 60 °C
and improves structure uniformity, Figure 1e−h. After the
formation of GE microbubbles at 40 °C, GE/HA microbubbles
were produced under the same conditions, proving that GE/
HA microbubbles remain stable and uniform, and the resultant
scaﬀolds retain a well-ordered honeycomb structure for a
longer period of time than GE scaﬀolds, as shown in Figure
1c,d. The stability of the microbubbles after cross-linking was
not studied in detail in this work, however, during the timespan
of experimental degradation (∼1 week), the bubbles were
stable in phosphate-buﬀered saline (PBS) under 37 °C. Thus,
the cross-linking helps to stabilize, i.e., retain both shape and
size.
As illustrated in Figure 2, the smallest diameter (295 μm
with a polydispersity index (PDI) of 0.01) microbubbles were
produced with solutions at 40 °C. The largest bubble diameter
(341 μm with a PDI of 0.04) was created with solutions at 60
°C. Microbubbles shrink as a function of time as gas dissolves
into the surrounding.8 The reduction in size leads to increased
stability (Figure 1). The stability of the microbubbles depends
on several resistance parameters like gravitational drainage,
Oswald’s ripening, and Laplace pressure, where gas diﬀusion
through the surrounding liquid shell is prompted by the
pressure gradient (Laplace pressure).32 This trend can be
explained by the fact that microbubbles made at 40 °C had
lower rates of gaseous diﬀusion into the liquid shell.8 As the
stability of microbubbles under ambient conditions is governed
by their radius and Laplace pressure is inversely related to
microbubble radius, smaller microbubbles have lower gas
exchange rates.8 Additionally, the resistance from their
condensed hard shell to gas permeation is also a vital
Figure 1. Structure of GE and GE/HA two-dimensional (2D) scaﬀolds, fabricated by microbubbles. From left to right, start point and after 2, 4,
and 10 min (a−d) GE/HA at 40 °C, (e−h) GE at 40 °C, (i−l) GE at 50 °C, (m−p) GE at 60 °C water bath temperature, respectively.
Figure 2. Eﬀect of temperature on microbubble size at diﬀerent
temperatures, 40, 50, and 60 °C.
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contributor to the stability of gas-ﬁlled microbubbles.33 The
higher solution viscosity (19.85 ± 0.71 mPa s, Table 1) at 40
°C condensed the relevant shells of microbubbles. Hence,
microbubbles produced at 40 °C are more stable, and the
resultant scaﬀolds have well-ordered honeycomb structures. As
a result, the temperature of the solution precursor aﬀects the
stability and quality of the microbubbles, due to the change in
solution viscosity (Figure 1).
Eﬀect of Solution Viscosity on Microbubble Diame-
ter. As shown in Figure 3, dimensionless diameter of
microbubbles produced by cross-ﬂow rupture technique
corresponds to the solution viscosity ratio (Table 2) of the
dispersed phase to that of the continuous phase. In other
words, the diameter of microbubbles increased with decreasing
continuous phase viscosity, where dimensionless microbubble
diameter is the ratio of diameter of microbubbles to the size of
channel (200 μm in Figure 1). However, the relative surface
tension of 0.6 and relative density of 0.9 are kept constant and
unaﬀected by the change of solution viscosity ratio, where the
relative surface tension and density are expressed as the ratio of
surface tension/density of dispersed phase to the surface
tension/density of continuous phase, respectively. Thus, the
relation between microbubble size and material properties can
be seen from Figure 3 where microbubble sizes generated in
the T-junction are decreased with increasing continuous phase
viscosity and independent of material surface tension. This can
be explained using the capillary number. There are several
dimensionless parameters that reveal the formation of droplets
and bubbles in microﬂuidic T-junctions. The key parameter
among them is capillary number, which is the ratio of viscosity
to interfacial tension.8 The diameter of bubbles decreases with
increasing capillary number.34 Therefore, microbubbles with a
nonsigniﬁcant surface tension deviation of 1% generated by
solution at 60 °C are larger than the size of microbubbles
produced at 40 °C.
Previous reports for gas−liquid systems observed that
average bubble size increased with increasing viscosity of the
continuous phase.35,36 This apparent contradiction is due to
the diﬀerent breakup mechanisms involved in diﬀerent
microﬂuidic techniques.37 The formation of microbubbles in
these reports35,36 was achieved by geometry-dominated
breakup, where the formation of microbubbles is dominated
by the spontaneous transformation caused by surface
tension.35,37 However, in this paper, microbubbles were
formed though the cross-ﬂow rupture technique (T-junction).
In this device, microbubble size is related to the ﬂow rate ratio
and phase viscosity.36,37
A well-structured scaﬀold is desirable as highly ordered and
uniform spatial structures are beneﬁcial for cell-to-cell and cell-
to-matrix interactions.7 As the 2D scaﬀold is well structured at
40 °C, 5 w/w % GE solution heated to 40 °C was chosen as
the base solution for all the following experiments.
Swelling Behavior. The swelling ratio of scaﬀolds plays a
vital role in maintaining the stability of the scaﬀold structure
and its mechanical properties when implanted in vivo.33
Hence, the swelling ratio is a key parameter to evaluate the
structural stability of GE scaﬀolds. Cross-linking is a necessary
step in preparing stable three-dimensional (3D) biopolymer
scaﬀolds18 as gelatin has poor mechanical properties and can
be easily dissolved in aqueous environments.38 According to
previous reports, scaﬀold porosity does not change signiﬁcantly
after cross-linking.39 To remove uncrosslinked glutaraldehyde
residues, phosphate buﬀer solution was used to rinse the
scaﬀolds. To ensure the removal of any residual chemicals,
scaﬀolds were immersed in chilled PBS solution which was
changed every hour, for the ﬁrst 4 h, and then immersed in
PBS solution for 20 h more at 4 °C, in comparison with other
studies, where the samples were rinsed twice or thrice.40−42 To
improve the biocompatibility of the scaﬀolds, the concen-
tration of GA was lowered, and the scaﬀolds were rinsed four
times in total and kept incubated for 24 h, since in other
studies the samples were cross-linked with higher concen-
trations under higher temperatures, resulting in a higher risk of
cytotoxicity,43 or GE/HA scaﬀolds were rinsed less than four
times in total and not incubated in PBS. The purpose of this
section is to investigate the swelling behavior of scaﬀolds cross-
linked with diﬀerent concentrations of glutaraldehyde.
Figure 4 shows the swelling ratio of scaﬀolds decreasing with
increasing concentrations of the cross-linking agent GA. The
least stable scaﬀolds cross-linked by 1% GA had the highest
swelling property within 24 h. However, the structures of
scaﬀolds with 1% cross-linker collapsed and dissolved after
1440 min. The structures for 5 and 10% GA cross-linked
scaﬀolds were stable after 1440 min. Scaﬀolds with 10% cross-
linker had the lowest water absorption, with a swelling ratio of
approximately 20% after 1440 min. This compares with
scaﬀolds cross-linked with 5% GA where the swelling ratio is
24%, a 4% increase compared to 10% GA. Thus, the higher GA
concentration produces a lower swelling ratio. This is due to
the diﬀerent cross-linking eﬃciencies of diﬀerent GA
concentrations. It was reported previously33 that higher
cross-linker concentrations could dramatically enhance the
cross-link eﬃciency.
Water is attracted to the hydrophilic un-cross-linked amino
groups, which leads to a greater solvent volume fraction within
the scaﬀolds. As cross-linking of gelatin can be explained by the
reaction between the aldehyde functional groups and free ε-
amino groups (−NH2) of lysine and hydroxylysine,44 hydro-
philicity is decreased with increasing the concentrations of
cross-linker, as the nucleophilic addition of the ε-NH2 groups
to the carbonyl groups (CO) of the aldehyde forms a
Figure 3. Relative value for 5 w/w % GE solution at 40, 50, and 60 °C
of density, surface tension, and dimensionless microbubble diameter
as a function of solution viscosity ratio.
Table 2. Eﬀect of Solution Temperature on Viscosity Ratio
of 5 w/w % GE, Where Viscosity Ratio Represents the Ratio
of the Dispersed Phase (Nitrogen) to the Continuous Phase
temperature (°C) 40 50 60
viscosity ratio 0.0009 0.0031 0.0038
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carbinolamine in a condensation reaction.44 Thus, 10% GA
cross-linked scaﬀolds had the lowest swelling ratio and water
uptake ability as more amino groups were cross-linked under
10% GA compared with 1 and 5% GA resulting in greater loss
of hydrophilic groups. Therefore, 5% GA was used to cross-
link 5 w/w % GE scaﬀolds in subsequent degradation and
antibacterial expriments, since these scaﬀolds have a good
balance between high absorbency and good structural stability
which are the two main desirable factors for cell adhesion and
growth.1
Figure 5 indicates the swelling ratios as a function of time for
GE/HA scaﬀolds compared to GE scaﬀolds of the same GE
concentration (5 w/w %) and cross-linked with the same GA
concentration (5 w/w %, data taken from Figure 4 for
comparison). The swelling ratios increased signiﬁcantly with a
steep gradient within the initial 10 min, and then an increase
with a smaller gradient up to 1440 min for both scaﬀolds. The
swelling ratios for GE and GE/HA scaﬀolds were almost
identical in the ﬁrst 10 min since rapid swelling is a result of
the un-cross-linked hydrophilic amino groups remaining inside
both GE and GE/HA scaﬀolds. The high porosity of both
scaﬀolds permits rapid inﬁltration of the PBS solution into the
scaﬀolds.45 GE and GE/HA scaﬀolds display a less-steep
increasing gradient after the ﬁrst 10 min as they approach
hydrodynamic equilibrium. This indicates that after the ﬁrst 10
min, as hydration of the GE/HA matrix approaches saturation,
the scaﬀold starts to absorb less water.45 The swelling ratio is
almost 1.3 times lower with the presence of HA in the
scaﬀolds, compounding the eﬀect of GA cross-linking on HA,
as shown in Figure 5. This is due to the cross-linking reaction
between GA and hydroxyl (−OH) groups of HA leading to a
reduction in the hydrophilicity of HA, resulting in a decrease of
the swelling ratio of GE/HA scaﬀolds in comparison to the GE
scaﬀolds.46 Despite this, the GE/HA scaﬀolds appear to have
retained some good swelling capabilities of ∼18% after 1440
min.
In Vitro Degradation. The resistance to hydrolytic
degradation of GE and GE/HA scaﬀolds treated with 5 w/w
% of GA is shown in Figure 6, which demonstrates the weight
loss of scaﬀolds as a function of incubation time in PBS at 37
°C (pH 7.4). The mass loss is associated with protein
dissolution into the surrounding PBS aqueous solution.39 The
data for GE scaﬀolds prior to cross-linking was not included as
it dissolved completely in PBS within the ﬁrst hour of
incubation. This is due to the lower resistance of un-cross-
linked scaﬀolds to hydrolytic degradation.47 Hence, cross-
linking has an impact on the scaﬀold binding capability and
degradation kinetics due to the formation of intermolecular
bonds. Compared to un-cross-linked scaﬀolds, in vitro
degradation tests demonstrate that GA cross-linking can
eﬀectively improve the stability of the scaﬀolds. Here, Figure
6 shows the comparison of mass loss between GE scaﬀolds and
GE/HA scaﬀolds over time, under incubation in PBS solution
at 37 °C.
Figure 6 indicates that the rate of degradation in HA-
containing scaﬀolds decreased with the presence of HA
content. GE/HA scaﬀolds showed a weight loss of 8% after
1 day, whereas GE scaﬀolds displayed a weight loss of 21%
after 3 days. This is due to the diﬀerence in the extent of cross-
linking within the diﬀerent scaﬀolds which results in diﬀerent
hydrophilicity. GE/HA scaﬀolds had stronger intermolecular
bonds and correspondingly lower hydrophilicity. The increase
in the weight loss of GE scaﬀolds was due to greater water
absorption, as the hydrophilic surface of GE enhances
inﬁltration of water into the polymer matrix, leading to a
higher rate of protein dissolution into the surrounding liquid,
therefore increasing the scaﬀolds’ degradation.48 However, the
cross-linking reaction reduces the hydrophilicity of GE/HA
scaﬀolds, which results in a decrease in the water absorption
and therefore a decrease in the rate of degradation.46 Data
were expressed as mean ± SD (n = 3). The apparent reversal
Figure 4. Eﬀect of diﬀerent cross-link concentrations, 1, 5, and 10%
GA, on water uptake capability of GE scaﬀolds. Each measurement
was repeated for ﬁve times and values were expressed in mean ±
standard error of the mean. Two-way ANOVA was carried out
followed by post hoc Tukey multiple comparison tests. GE solutions
(5 wt %) with three diﬀerent glutaraldehyde ratios were compared
and values are represented statistically when *p < 0.05 in comparison
with cross-linked 5 w/w % GA and +p < 0.05 when compared with
cross-linked 10 w/w % GA. Statistical analysis was performed using
the GraphPad Prism 6.0 software (GraphPad Software, Inc., San
Diego, CA).
Figure 5. Comparison of the water uptake capability between GE
scaﬀolds and GE/HA scaﬀolds over time, under incubation in PBS
solution.
Figure 6. Comparison of mass loss between GE scaﬀolds and GE/HA
scaﬀolds over time, under incubation in PBS solution at 37 °C.
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of mass loss after 1 day for GE/HA scaﬀolds can be explained
by the possibility that water penetration has not reached the
core of the scaﬀold on account of the reduced hydrophilicity
relative to GE scaﬀolds. As a result, during drying, water from
only the periphery is removed, and mass loss is observed via
protein dissolution from the periphery. After immersion for >3
days, however, the time is suﬃcient to allow water to diﬀuse
into the core of the scaﬀold. In this scenario, it is likely that 24
h of desiccation is insuﬃcient to fully remove water from the
core of the scaﬀold leading to an apparent reduction in the
mass loss. This appears to be mirrored in the GE scenario
albeit with a delay, with the apparent decrease occurring after 4
days. Due to its resistance to rapid degradation, GE/HA
scaﬀolds were loaded with lactoferrin and assessed for
antibacterial properties.
Antibacterial Activity. The materials that were used in
this study to fabricate the scaﬀolds are biodegradable natural
polymers and are derivatives of proteins found naturally in the
ECM. For this reason, they have been used in the fabrication of
scaﬀolds for tissue engineering using diﬀerent techniques. It is
well known that diﬀerent bacterial adhesins can recognize
several elements of host−cell surfaces, such as components of
the extracellular matrix, including collagens, laminins, elastin,
proteoglycans, and hyaluronic acid,49 resulting in bacterial
adhesion. In this case, the bacterial adhesion in scaﬀolds can be
promoted as the size of bacteria (0.5 μm)50 allows their
inﬁltration and attachment on to the large pores of the
scaﬀolds.39 For this reason, antibacterial properties are highly
desired for scaﬀolds, and this was a major aim of this study.
The inclusion of HA into GE scaﬀolds (GE/HA) results in a
reduction of bacteria growth by almost 35%, in comparison
with the GE scaﬀolds, which do not show any antibacterial
activity. Antibacterial activity was evident despite the low
concentration (2.5 mg/mL) of HA in comparison with other
reported values in the literature.18,21
To further decrease the bacterial growth, GE/HA scaﬀolds
were immersed, after their preparation, in lactoferrin (LF)
solution for 3 h. LF was chosen for its antiviral, antibacterial,
antiparasitic, and antifungal properties.21,51
Figure 7 shows the growth inhibition, which was determined
by measuring the absorbance of the supernatant at 600 nm,
after its incubation in media at 37 °C overnight. Figure 7
shows a reduction in bacterial growth of 35% for GE/HA
scaﬀolds and 70% for GE/HA scaﬀolds loaded with LF (p <
0.05) in comparison with GE scaﬀolds. As GE/HA scaﬀolds
have a good water uptake capability, scaﬀolds absorbed
lactoferrin (LF) solution after being immersed, resulting in a
further decrease of the bacterial growth. This demonstrates the
feasibility of producing scaﬀolds with antibacterial activity from
monodispersed microbubbles manufactured using a T-Junction
microﬂuidic device.
■ CONCLUSIONS
A microﬂuidic single T-junction has been adopted to produce
monodispersed microbubbles. Subsequently, stable GE/HA
scaﬀolds were obtained by drying microbubbles with the aid of
GA cross-linking. Stable and well-structured microbubbles
could be produced by keeping solutions at 40 °C during
processing. Scaﬀolds cross-linked with 5% GA solution showed
good water absorption which could be used to prevent the loss
of body ﬂuid and nutrients from scaﬀolds during culturing in
vitro and implanting in vivo. The incorporation of HA
decreases the absorptive capabilities of the scaﬀold (which
are still signiﬁcant at 18%) and lowers the rate of degradation.
The antibacterial properties of GE/HA scaﬀolds were capable
of reducing bacterial growth despite a low concentration of 2.5
mg/mL. Antibacterial activity can be improved by immersing
the GE/HA scaﬀolds in LF solution. The GE/HA scaﬀolds
combine the advantages of gelatin and HA (e.g., good water
uptake capability, biodegradable, ECM constituents) and may
be a suitable candidate for use in wound-healing patches, soft
tissue engineering, or as coatings for implanted medical
devices.
Microbubbles oﬀer a simple robust and inexpensive method
for scaﬀold fabrication. The present work could provide the
experimental basis for further cell growth and in vivo studies
on GE/HA microbubble scaﬀolds using microﬂuidics.
■ EXPERIMENTAL MATERIALS AND METHODS
Materials. Gelatin (Type B, bovine skin, approx 225 g
Bloom), HA (sodium salt, (1.5−1.8) × 106 Da), Lactoferrin
(bovine milk, 87 × 103 Da), and Glutaraldehyde (Grade II,
25% in H2O, 100.12 Da) were purchased from Sigma-Aldrich
Co. All of the materials and reagents were used without further
puriﬁcation.
Solution Preparation. GE solution, 5% (w/w), was
prepared by dissolving gelatin in deionized water at 40, 50,
or 60 °C with a magnetic stirrer for 1 h. The solution was
heated with a temperature controller (Warner Instruments,
model TC-124A) during microbubble generation to prevent
gelation. GE/HA was prepared by mixing the GE with 25 mg
of HA in 10 mL of deionized water, stirring for 1 h at 40 °C
under the same conditions as GE. LF solution was prepared by
dissolving 1 mg/mL in deionized water at room temperature
(20 °C) stirring for 15 min.
Microbubble Scaﬀold Fabrication. The experiments for
microbubble generation were performed in a T-junction
microﬂuidic device made of poly(dimethylsiloxane). Two
Teﬂon ﬂuorinated ethylene polypropylene microchannels,
200 μm in diameter, were used perpendicularly to each other
for the continuous phase (liquid ﬂow) and the dispersed phase
(gas ﬂow). For the continuous phase and the dispersed phase,
liquid solutions of GE, GE/HA, and N2 gas were used. The
conﬂuence junction of the two phases penetrated into a third
microchannel with 200 μm diameter, a microbubble begins to
grow, as the gas pressure and the ﬂow in the main channel
distort the bubble in the downstream direction, shown in
Figure 8.
Breakup of the gas−liquid streams is dominated by the
pressure drop across the bubble as it forms. The aqueous
solutions are loaded into a syringe and placed in the syringe
Figure 7. Antibacterial behavior of diﬀerent scaﬀolds when cultured
with S. aureus (p < 0.05).
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pump (Harvard Apparatus Ltd., Edenbridge U.K.), which
delivers the solution to the microchannel. At the same time, N2
gas was passed through the other microchannel resulting in
microbubble formation. Monodispersed microbubbles sponta-
neously self-assembled into liquid foam structures and after
leaving them to dry, were solidiﬁed.52 During the drying
process, due to the pressure diﬀerence between the bubbles
and the ambient atmosphere, the ﬁlm of the bubbles bursts,
leaving only the plateau borders, resulting in structure creation.
By collecting the microbubbles on a glass slide enable forming
of multiple layers of the microbubbles. By collecting the
microbubbles on a glass slide, 3D scaﬀolds were formed from
the multiple layers of the microbubbles. GE scaﬀolds were
cross-linked with 1, 5, and 10% concentrations of GA solution.
GE/HA scaﬀolds were cross-linked with 5% of GA. The cross-
linked GE and GE/HA scaﬀolds were then immersed in PBS
solution at 4 °C for 24 h to completely remove any residues of
GA. GE/HA scaﬀolds were later immersed in lactoferrin (LF)
solution to load them with LF.
Stability Study. GE (5 w/w %) was chosen as the
continuous phase to generate microbubbles. Three GE
solutions were made by dissolving 5 w/w % gelatin in
deionized water at temperatures of 40, 50, and 60 °C,
separately. Material characterization was carried out at room
temperature. The mean diameter of microbubbles produced at
various gas pressures and ﬂow rates was measured as a function
of time. For each sample, 100 microbubbles were chosen
stochastically and measured every 2 min until all of the
microbubbles burst or their GE shell dried. The eﬀect of the
temperature on the stability, structure, and size of microbubble
was studied.
Visualization and Analysis. Scaﬀolds were observed
under an optical microscope (Zeiss Axiotech, Germany) ﬁtted
with a camera (Nikon Eclipse ME 600, Japan) at a
magniﬁcation of 5×. A high-speed Phantom v5.0 camera
with a maximum resolution of 800 × 600 pixels at up to 4800
fps with a recording time of 1.2 s was used to record live
microbubble formation videos (see Supporting Information).
The bubble-formation processes were analyzed under diﬀerent
ﬂow rate ratio conditions. The size and structure of
microbubbles were captured using the same microscope.
Measuring the diameter of at least 100 microbubbles per
sample by using Image J software, we were able to calculate the
average bubble diameter (dav) and the polydispersity index
(σ). Polydispersity index is deﬁned by the following equation
/dav 100%σ δ= × (1)
where δ is the standard deviation.
Cross-Linking of Scaﬀolds. Three diﬀerent cross-linker
solutions of 1, 5, and 10 w/w % concentrations of GA were
prepared in 10 mL of deionized water. Cross-linker
concentrations of GA (1, 5, and 10 w/w %) were applied on
scaﬀolds. The samples were dried in ambient conditions for 24
h. Scaﬀolds were then rinsed with PBS every 1 h for the ﬁrst 4
h and then immersed in PBS for a further 20 h at 4 °C to
remove residual GA.
Characterization of Scaﬀolds. The swelling ratio allows
us to determine the capacity of the hydrogel to imbibe large
amounts of water.53 GE scaﬀolds were cross-linked with a 1, 5,
or 10% solution of GA. The scaﬀolds were then dried and
weighed (Wd). Scaﬀolds were then immersed in phosphate-
buﬀered saline (PBS, pH 7.4) for 24 h at 37 °C. The wet
weight (Wt) of the samples was measured after 10, 20, 30, 60,
120, 180, and 1440 min. Swelling ratio was calculated using the
eq 2
W W WSR ( )/ 100%t d d= − × (2)
where SR is the swelling ratio (%) and is deﬁned1 as the ratio
of the weight increase (Wt − Wd) to the initial dry weight
(Wd).
In vitro degradation of scaﬀolds was investigated by
measuring weight loss over time under static culture
conditions. The weight loss was calculated from the diﬀerence
between the weight of samples at the start of experiment and
the residual weight after immersing samples in PBS solution for
a period of 5 days.49 Experiments were performed in PBS
buﬀer at 37 °C every day for 5 days to mimic a biological
environment. Then, scaﬀolds were taken out of solutions daily
and placed in a desiccator to dry for 24 h before residual
weight measurement (Wr). The extent of the in vitro
degradation was calculated as the percentage of weight loss
before and after PBS treatment1 using the equation given
W W W W( )/ 100%l 0 r 0= − × (3)
where Wl is the percentage of weight loss, W0 is the weight of
scaﬀolds at the start of experiment, and Wr is the sample
weight after desiccator drying. Degradation tests have been
deﬁned as the degradation involving backbone chain breakage
and a diminution in average molecular weight.54 Here, the
degradation test helps us understand how facilely the scaﬀold
can be degraded over time.
The experiments for swell ratio and degradation were
conducted three times, and all values were reported as the
mean and standard deviation.
Antibacterial Assay. S. aureus (ATCC 25923) was used to
check the antibacterial properties of the samples. Bacterial
strain was cultured aerobically at 37 °C in a Tryptic Soy Broth
(TSB) medium at pH 7.4. One colony was transferred to 10
mL of TSB medium and incubated at 37 °C for 20 h. To
obtain bacteria in the mid logarithmic phase growth, the
absorbance (600 nm) of overnight culture was adjusted to
0.00022, corresponding to a ﬁnal density of 105 CFU/mL.
Scaﬀolds were placed into a 96-well plate and sterilized using
UVGI for 15 min. After the sterilization, 180 μL of S. aureus,
A600 = 0.00022, was added to each well and incubated for 24 h
at 37 °C. For the negative control, gelatin scaﬀolds were
Figure 8. Schematic representation of the process of bubble
generation in a T-junction cross-ﬂow microﬂuidic device setup.
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incubated with S. aureus using the same method. For the
positive control, penicillin streptomycin (Pen Strep) was
added. To check the bacterial growth or inhibition after 24 h,
the absorbance of the supernatant at 600 nm was measured.
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